Skip to content

A comparative study of lesser dose of carbetocin versus regular dose of carbetocin in the prevention of bleeding during planned cesarean delivery

A comparative study of lower dose of Carbetocin versus standard dose of Carbetocin in the prevention of postpartum hemorrhage during elective cesarean section. - LOWCARB

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/03/041222
Enrollment
212
Registered
2022-03-21
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O721- Other immediate postpartum hemorrhage

Interventions

Intervention1: Carbetocin: Group I shall be administered 50 mcg of carbetocin as a bolus dose IV within one minute of the delivery of the baby by cesararean section The dose shall be administered over

Sponsors

Dr Rajasri G Yaliwal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Consenting Term pregnancy(37-42 weeks of gestation) undergoing elective LSCS under subarachanoid block (Spinal Anesthesia)

Exclusion criteria

Exclusion criteria: 1.Women in labour 2. Women having Coagulopathies 3. Women with Hypertensive disorder 4. Women with cardiaovascular disorders, hepatic and renal diseases 5. Women with Epilepsy 6. Women having known conditions predisposing to atonic PPH like hydramnios, Multiple gestation prolonged labor. 7. Women requiring General Anaesthesia

Design outcomes

Primary

MeasureTime frame
Assessment of blood loss: Change in the pre and post hemoglobin levels and hematocritTimepoint: 72 hours after the operation

Secondary

MeasureTime frame
cardoivasular changes and tone of the uterusTimepoint: 1 min 5min 10min 15min 1hour

Countries

India

Contacts

Public ContactDr Rajasri G Yaliwal

BLDE(DU) Shri BM Patil medical College Hospital and Resrarch Center

patilneelgiri@rediffmail.com9845152240

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026